Mangalam Drugs and Organics Limited announced the outcome of its Board Meeting held on January 15, 2026. The Board approved the Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended January 15, 2026, along with the Limited Review Report.

The meeting also noted the resignation of Mr. Ajay Samant, Chief Financial Officer, effective January 31, 2026, due to health reasons. He had tendered his resignation on November 5, 2025. Additionally, the Board took note of the resignation of Ms. Anuradha Pandey, Company Secretary & Compliance Officer, tendered on January 2, 2026, to be effective March 29, 2026, as she seeks to pursue other career opportunities.

The Board meeting commenced at 12:00 PM and concluded at 2:30 PM. The company also declared that its statutory auditors have not expressed any modified opinions in their audit reports regarding the Un-Audited Financial Results.